Gadolinium Retention in Human Bone Tissue in Pediatric Patients: A Comparison of Dotarem Versus MultiHance MRI Contrast Agents
Latest Information Update: 01 Aug 2024
At a glance
- Drugs Gadobenic acid (Primary) ; Gadoterate-meglumine (Primary)
- Indications Cardiovascular disorders
- Focus Diagnostic use
- 30 Jul 2024 Planned End Date changed from 1 Jun 2024 to 1 Sep 2024.
- 30 Jul 2024 Planned primary completion date changed from 1 Jun 2024 to 31 Aug 2024.
- 11 May 2023 Planned End Date changed from 1 Jun 2023 to 1 Jun 2024.